The dawn of the CRISPR/Cas9 gene therapy era.
The Lancet. Haematology, 11(1): e1 PMID 38135367 DOI 10.1016/S2352-3026(23)00372-1
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.